loading
Novabay Pharmaceuticals Inc stock is traded at $0.5935, with a volume of 30,504. It is up +2.15% in the last 24 hours and down -2.55% over the past month. NovaBay Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets non-antibiotic and anti-infective products for the eye care market in the United States, China, and internationally. It offers Avenova, a prescription product for cleansing and removing foreign materials, including microorganisms and debris from skin around the eye; NeutroPhase for wound care market; CelleRx for the aesthetic dermatology market; Aganocide compounds patented synthetic molecules for use against bacteria, viruses, and fungi; auriclosene irrigation solution for urology; and intelli-Case, a device for soft and rigid gas permeable contact lenses. NovaBay Pharmaceuticals, Inc. has collaboration and license agreement with Virbac to develop auriclosene, a proprietary compound for veterinary markets. The company was formerly known as NovaCal Pharmaceuticals, Inc. and changed its name to NovaBay Pharmaceuticals, Inc. in February 2007. NovaBay Pharmaceuticals, Inc. was incorporated in 2000 and is based in Emeryville, California.
See More
Previous Close:
$0.581
Open:
$0.6
24h Volume:
30,504
Relative Volume:
0.81
Market Cap:
$3.45M
Revenue:
$14.64M
Net Income/Loss:
$-13.74M
P/E Ratio:
-0.0816
EPS:
-7.27
Net Cash Flow:
$-5.04M
1W Performance:
-11.73%
1M Performance:
-2.55%
6M Performance:
-10.82%
1Y Performance:
+9.95%
1-Day Range:
Value
$0.57
$0.6196
1-Week Range:
Value
$0.57
$0.6742
52-Week Range:
Value
$0.3611
$1.0099

Novabay Pharmaceuticals Inc Stock (NBY) Company Profile

Name
Name
Novabay Pharmaceuticals Inc
Name
Phone
510-899-8800
Name
Address
2000 Powell Street, Suite 1150, Emeryville, CA
Name
Employee
86
Name
Twitter
@NovaBayPharma
Name
Next Earnings Date
2024-11-07
Name
Latest SEC Filings
Name
NBY's Discussions on Twitter

Compare NBY with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
NBY
Novabay Pharmaceuticals Inc
0.5935 3.38M 14.64M -13.74M -5.04M -7.27
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
462.13 117.32B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
558.87 58.89B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
401.80 51.14B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
673.80 41.02B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
299.01 32.59B 3.81B -644.79M -669.77M -6.24

Novabay Pharmaceuticals Inc Stock (NBY) Upgrades & Downgrades

Date Action Analyst Rating Change
Sep-18-19 Initiated Ladenburg Thalmann Buy
Jul-06-18 Reiterated H.C. Wainwright Buy
Nov-15-17 Reiterated Laidlaw Buy
Jun-05-17 Initiated ROTH Capital Buy
Mar-27-17 Initiated Laidlaw Buy
Feb-06-17 Initiated Rodman & Renshaw Buy
Mar-07-16 Downgrade Maxim Group Buy → Hold
Dec-14-15 Reiterated Maxim Group Buy
Apr-30-15 Resumed Maxim Group Buy
Mar-06-13 Initiated Ascendiant Capital Markets Strong Buy
Jan-03-08 Initiated Dawson James Speculative Buy
View All

Novabay Pharmaceuticals Inc Stock (NBY) Latest News

pulisher
02:50 AM

Why NovaBay Pharmaceuticals Inc. stock attracts strong analyst attentionEarly Entry Ideas with Momentum Potential - Newser

02:50 AM
pulisher
01:33 AM

Analyzing NovaBay Pharmaceuticals Inc. with multi timeframe chartsTop Stock Picks with Forecast Accuracy - Newser

01:33 AM
pulisher
Aug 01, 2025

Short interest data insights for NovaBay Pharmaceuticals Inc.Free Short Term Buy Zone Stock Alerts - Newser

Aug 01, 2025
pulisher
Aug 01, 2025

How institutional ownership impacts NovaBay Pharmaceuticals Inc. stockFuture Growth Stock Forecasting Strategy - Newser

Aug 01, 2025
pulisher
Aug 01, 2025

Signal strength of NovaBay Pharmaceuticals Inc. stock in tech scannersFree Opportunity Map for Daily Stock Trading - Newser

Aug 01, 2025
pulisher
Jul 31, 2025

What MACD signals say about NovaBay Pharmaceuticals Inc.Loss Limitation Strategy Based on Analysis - Newser

Jul 31, 2025
pulisher
Jul 31, 2025

What’s next for NovaBay Pharmaceuticals Inc. stock priceSmart Risk Strategy with Entry Optimization - Newser

Jul 31, 2025
pulisher
Jul 31, 2025

When is the best time to buy NovaBay Pharmaceuticals Inc. stockTechnical Trade Plan with Entry Checklist - Newser

Jul 31, 2025
pulisher
Jul 31, 2025

Can machine learning forecast NovaBay Pharmaceuticals Inc. recoveryTechnical Safety Zone Pattern Recognition - Newser

Jul 31, 2025
pulisher
Jul 31, 2025

News impact scoring models applied to NovaBay Pharmaceuticals Inc.Daily Investment Ideas with Market Insight - Newser

Jul 31, 2025
pulisher
Jul 30, 2025

Analyzing recovery setups for NovaBay Pharmaceuticals Inc. investorsFree Investment Plan With Growth Optimization - Newser

Jul 30, 2025
pulisher
Jul 30, 2025

How Resilient Is NovaBay Pharmaceuticals Inc. Stock During Economic DownturnsVolatility Analysis and Entry Risk Mapping - Newser

Jul 30, 2025
pulisher
Jul 30, 2025

Developing predictive dashboards with NovaBay Pharmaceuticals Inc. dataShort Term Opportunity Finder with Tools - Newser

Jul 30, 2025
pulisher
Jul 29, 2025

Market reaction to NovaBay Pharmaceuticals Inc.’s recent newsLong-Term Investment Strategy Impact Analysis - Newser

Jul 29, 2025
pulisher
Jul 29, 2025

Using Ichimoku Cloud for NovaBay Pharmaceuticals Inc. technicalsFree Accurate Technical Trend Reversal Picks - Newser

Jul 29, 2025
pulisher
Jul 29, 2025

NovaBay Pharmaceuticals Inc. Price Targets Raised After ReboundFast Gaining Stock Screener Reports Released - metal.it

Jul 29, 2025
pulisher
Jul 28, 2025

Elliott Wave Theory Predicts Pullback in NovaBay Pharmaceuticals Inc.Weekly Return Pick Forecast Reports Show Trend - metal.it

Jul 28, 2025
pulisher
Jul 28, 2025

What makes NovaBay Pharmaceuticals Inc. stock price move sharplyBreakthrough stock performance - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

Using data tools to time your NovaBay Pharmaceuticals Inc. exitExpert-Backed High Yield Stock Watchlist - Newser

Jul 28, 2025
pulisher
Jul 28, 2025

When is NovaBay Pharmaceuticals Inc. stock expected to show significant growthEarnings Report Ideas With High Returns - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

Why NovaBay Pharmaceuticals Inc. stock attracts strong analyst attention Pattern Recognition Based Market Move Prediction - Newser

Jul 28, 2025
pulisher
Jul 28, 2025

Short interest data insights for NovaBay Pharmaceuticals Inc. Free Short Term Buy Zone Stock Alerts - Newser

Jul 28, 2025
pulisher
Jul 28, 2025

What institutional investors are buying NovaBay Pharmaceuticals Inc. stockAchieve superior capital gains with smart trades - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 27, 2025

Should I hold or sell NovaBay Pharmaceuticals Inc. stock in 2025Capitalize on emerging industry trends - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

Is NovaBay Pharmaceuticals Inc. stock overvalued or undervaluedGet timely alerts on top market movers - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

How does NovaBay Pharmaceuticals Inc. compare to its industry peersBreakthrough profit margins - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

Buy Signal for NovaBay Pharmaceuticals Inc. Stock Key Technical Indicators to WatchHigh Probability Setups - Newser

Jul 27, 2025
pulisher
Jul 25, 2025

Is NovaBay Pharmaceuticals Inc. a good long term investmentUnmatched market gains - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

How NovaBay Pharmaceuticals Inc. stock reacts to Fed policy changesMarket-leading growth rates - jammulinksnews.com

Jul 25, 2025
pulisher
Jul 25, 2025

What analysts say about NovaBay Pharmaceuticals Inc. stockFree Market Dynamics Reports - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

NovaBay Pharmaceuticals Inc. Stock Analysis and ForecastUnbelievable profit margins - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 23, 2025

What drives NovaBay Pharmaceuticals Inc. stock priceFree Investment Risk Control - Autocar Professional

Jul 23, 2025

Novabay Pharmaceuticals Inc Stock (NBY) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$75.59
price up icon 0.93%
$37.11
price up icon 0.84%
$108.69
price up icon 1.31%
$27.07
price up icon 2.65%
$107.34
price down icon 0.15%
biotechnology ONC
$299.01
price down icon 0.70%
Cap:     |  Volume (24h):